4Claudel JP,Touboul P.Sotalol:from"just another beta blocker"to"the prototype of class Ⅲ antidysrhythmic compound"[J].Pacing Clin Elect rophysiol,1995,18:451.
5Hohnloser Sh,Zabel M,Van de LooA,et al.Efficacy and safety of sotalol in patients with complex ventricular arrhythmias[J].lnt J Cardiol,1992,37(3):283.
6Carusoglu E,Frishman WH.Sotalol:a new β-advenergic blocker for ventricular arrhythmias[J] .Pro Cardiovase Dis,1995,37(6):423.
7Singh BN.Electrophsiologie basis for the antiarrhythmicaction of STL and comparison with other agents[J] .Am J Cardiol,1993,72(4,):8.
8Melecot CO,Argibay JA.Block of gating currents relate to K-channel as a mechanisrn of action of clofilium and sotalol in isolated guinea pig ventricular heart cells[J].Br J Pharmacol,1999,128(2) :301.
9Aidonidis 1,Rizos I,Hilbel T,et al.Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia:comparison wit h the beta- 1 receptor antagonist bisoprolol[J] .J Mol Cell Cardiol,1994,26(7) :841.
10Lynch J J,Coskey LA,Montgomery DG,et al.Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death[J] .Am Heart J,1995,109:949.
